Deep Bio Presents Research Results of AI-based Cancer Diagnosis and Prognosis at the AACR Annual Meeting 2022 Five abstracts in prostate and breast cancers, Deep Bioโs main research areas, are present...
DeepBio has announced that its deep learning-based prostate cancer pathology diagnosis technology using a Gleason grading system acquired NET (new excellent technology) certification on Tuesday...
DeepBio said its DeepDx-Prostate Pro, an artificial intelligence (AI)-based pathology diagnosis assistance software, has received a Class 3 in-vitro diagnostic medical device from the Ministry of Food...
SPOKANE, Wash. and SEOUL, South Korea, July 14, 2021 /PRNewswire/ — Gestalt Diagnostics and Deep Bio today announced their strategic relationship on the development of an integrated workflow for...